Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,564,895
-
Share change
-
+3,322,248
-
Total reported value
-
$3,270,421,904
-
Put/Call ratio
-
94%
-
Price per share
-
$91.96
-
Number of holders
-
189
-
Value change
-
+$311,576,416
-
Number of buys
-
124
-
Number of sells
-
68
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2015
As of 30 Sep 2015,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,564,895 shares.
The largest 10 holders included
FMR LLC, Palo Alto Investors, LLC, Partner Fund Management, L.P., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, OPPENHEIMER FUNDS INC, Antipodean Advisors LLC, BlackRock Fund Advisors, NEA Management Company, LLC, and ORBIMED ADVISORS LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.